生物技术公司Vaxcyte, Inc.近日宣布,公司计划于2026年2月24日发布其2025年第四季度及全年的财务业绩报告。此次公告不仅将详细披露关键财务数据,还将同步更新公司最新的业务进展与战略规划。
投资者与市场分析师可通过官方渠道获取具体财报发布时间及电话会议接入信息,届时管理层将现场解读业绩表现并回应市场关切。
生物技术公司Vaxcyte, Inc.近日宣布,公司计划于2026年2月24日发布其2025年第四季度及全年的财务业绩报告。此次公告不仅将详细披露关键财务数据,还将同步更新公司最新的业务进展与战略规划。
投资者与市场分析师可通过官方渠道获取具体财报发布时间及电话会议接入信息,届时管理层将现场解读业绩表现并回应市场关切。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.